Related Experiment Video
Updated: May 5, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Emerging topical treatments for psoriasis.
Dario N Kivelevitch1, Katherine R Hebeler, Mahir Patel
1Baylor University Medical Center, Department of Dermatology , 3900 Junius Street, Suite 125, Dallas, TX 75246 , USA +1972 354 7988 ; +1 972 715 1460 ; amderm@gmail.com.
New topical treatments for psoriasis are emerging, offering hope for patients with mild-to-moderate disease. These innovative options aim to improve upon current topical therapies, which have seen little advancement.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Mild-to-moderate psoriasis affects 80% of patients, typically treated with topical medications.
- Current topical treatments have seen limited innovation over decades.
Purpose of the Study:
- To review emerging topical drugs and formulations for psoriasis.
- To address the unmet need for novel topical treatments.
- To highlight advancements in topical psoriasis therapy.
Main Methods:
- Review of emerging topical drugs and formulations.
- Analysis of treatments currently in clinical trials.
- Evaluation of novel therapeutic approaches.
Main Results:
- Significant advances in systemic psoriasis therapies have occurred.
- Topical therapies for psoriasis have lagged behind systemic treatments.
- New topical agents with novel mechanisms of action are under development.
Conclusions:
- There is a critical need for innovative topical treatments for psoriasis.
- Advancements in topical psoriasis therapy are essential for the large patient population.
- Emerging topical drugs promise improved efficacy and safety profiles.
Related Concept Videos
Acne Infection
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

